Long-term response to pimitespib in postoperative recurrent gastrointestinal stromal tumors with PDGFRA D842V mutation: a case report.
Ryugo TeranishiTsuyoshi TakahashiYukinori KurokawaTakuro SaitoKazuyoshi YamamotoKotaro YamashitaKoji TanakaTomoki MakinoKiyokazu NakajimaHidetoshi EguchiYuichiro DokiPublished in: Surgical case reports (2023)
We report the first case of long-term response to PIMI in PDGFRA D842V mutant GIST. Pimitespib may be effective for treating GIST harboring this mutation by inhibiting HSP90.